Provided by Tiger Fintech (Singapore) Pte. Ltd.

Travere Therapeutics, Inc.

14.92
+0.35002.40%
Post-market: 14.920.00000.00%16:05 EDT
Volume:1.10M
Turnover:16.26M
Market Cap:1.32B
PE:-3.66
High:15.00
Open:14.56
Low:14.56
Close:14.57
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Oct 28, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 27, 2022

Major Issues Report

8-K - Current report
Oct 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Aug 22, 2022

Major Issues Report

8-K - Current report
Aug 18, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 17, 2022

Major Issues Report

8-K/A [Amend] - Current report
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 12, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 20, 2022

Major Issues Report

8-K - Current report